Intra-operative anesthetic induced myocardial protection during cardiothoracic surgery: a literature review
Journal of Thoracic Disease · 2023-12 · 15 (12) · 7042-7049
DOI: 10.21037/jtd-23-1101 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Thoracic Disease, 2023-12. Verfasst von Abey S Abraham und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Anesthesiology, Cleveland Clinic Foundation, Cleveland, OH, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and Objective: Myocardial protection involves limiting the metabolic activity and oxygen consumption of the heart, thus enabling surgery to proceed with minimal blood loss while reducing the level of ischemic injury. It was this concept that allowed for the development of the open-heart surgical technique. We know myocardial ischemia and reperfusion injury are both detrimental, thus developing strategies to mitigate this can help reduce peri-operative morbidity and mortality. In this review, we will mainly be addressing the anesthetic considerations for myocardial protection, along with discussing potential future research which can help expand the field.
Methods
We searched the PubMed database for relevant studies dating from 2004-2022. In total, 18 studies were deemed suitable for this literature review. Key Content and Findings: Studies have demonstrated cardioprotective effects with use of the volatile agents and propofol, mainly with respect to lower levels of inflammatory markers such as creatine kinase (CK)-MB and troponin I (TnI)/troponin T (TnT). The data is lacking regarding protective effects of dexmedetomidine and lidocaine, hence we cannot recommend either agent at present.
Conclusions
Myocardial protection with respect to the anesthetic agents have been extensively studied over the past two decades, some routinely used drugs such as the volatile agents, propofol and opiates have demonstrated a cardioprotective role. The ideal dosing regimen and duration are areas of research that can be studied further. The data for the other anesthetic adjuncts such as lidocaine, dexmedetomidine along with use of regional anesthesia is still equivocal. Alongside advances in anesthesia, we believe surgical research looking into optimal cardioplegia solutions will also help improve myocardial protection in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Anesthesiology, Cleveland Clinic Foundation, Cleveland, OH, USA.
- School of Medicine, University of Leeds, Leeds, UK.
- Department of Cardiothoracic Anesthesiology, Outcomes Research Consortium, Cleveland Clinic Foundation, Cleveland, OH, USA.
Zitieren
APA
Abraham, A. S., Elliott, C. W., Abraham, M. S., & Ahuja, S. (2023). Intra-operative anesthetic induced myocardial protection during cardiothoracic surgery: a literature review. Journal of Thoracic Disease, 15(12), 7042-7049. https://doi.org/10.21037/jtd-23-1101
Vancouver
Abraham AS, Elliott CW, Abraham MS, Ahuja S. Intra-operative anesthetic induced myocardial protection during cardiothoracic surgery: a literature review. Journal of Thoracic Disease. 2023;15(12):7042-7049. doi:10.21037/jtd-23-1101
BibTeX
@article{Abraham2023,
author = {Abraham, Abey S and Elliott, Connor W and Abraham, Matthew S and Ahuja, Sanchit},
title = {Intra-operative anesthetic induced myocardial protection during cardiothoracic surgery: a literature review},
journal = {Journal of Thoracic Disease},
year = {2023},
volume = {15},
number = {12},
pages = {7042--7049},
doi = {10.21037/jtd-23-1101}
}
EUVIMED